Vaccines

Coronavirus

In anticipation for future coronavirus vaccine studies we will need the help of our community of volunteers. Please visit our website to submit your interest in being part of future Covid-19 vaccine studies. Currently there are no available research studies for Covid-19, however, we are actively tracking a list of companies with plans to conduct vaccine studies this year. With your help, Rochester could be a part of the development of a potentially life saving vaccine.

Chikungunya Vaccine

Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the study Chikungunya vaccine in healthy adults over the age of 18 years old.

Men’s HPV Vaccine

The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45. The vaccine aims to prevent HPV infection which are associated with oral cancer. Compensation is available up to $1,300, for those who qualify.

*Compensation for time and travel may be available to those who qualify.

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.